Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: A European multicentre study

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 207-214

  Richard, M P ^a  

^a Rhone DPC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN G; SPARFLOXACIN; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; FRANCE; GERMANY; HAEMOPHILUS INFLUENZAE; HUMAN; HUNGARY; IRELAND; ITALY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NETHERLANDS; NONHUMAN; PENICILLIN RESISTANCE; PORTUGAL; SLOVAKIA; SPAIN; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; EUROPE; FLUOROQUINOLONES; HAEMOPHILUS INFLUENZAE; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; QUINOLONES; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031894715     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ellner, J. J. (1988). Management of acute and chronic respiratory tract infections. American Journal of Medicine 85, Suppl. 3A, S2-5.
2. La Force, F. M. (1992). Antibacterial therapy for lower respiratory tract infections in adults: a review. Clinical and Infectious Diseases, 14, Suppl. 2, 3233-7.
3. Moroni, M., Franzetti, F. & Antinori, S. (1992). Antibiotic therapy in bronchopulmonary infections. Annals of the Italian Medical lnterns7, 86S-Q3S.
4. Davies, B. 1. & Maeson, F. P. V. (1990). Treatment of Branhamella catarrhalis infections. Journal of Antimicrobial Chemotherapy25, 1-7.
5. Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W. & Redding, J. S. (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy34, 2075-80.
6. Wright, P. W. & Avery, W. G. (1989). Branhamella catarrhalis infections. American Family Physician 39, 125-8.
7. Feleke, G. & Khan, F. A. (1989). Branhamella infections: an increasingly common respiratory illness. Postgraduate Medical Journal 85, 379-86.
8. Applebaum, P. C. (1995). Comparative in vitro activity of sparfloxacin against organisms causing community-acquired lower respiratory tract infections. Canadian Journal of Infectious Diseases 6, Suppl. C, 206.
9. Baquero, F. & Canton, R. (1996). In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens. Journal of Antimicrobial Chemotherapy 37, SuppJ.A1-18.
10. Spéciale, A., Blandino, G., Nicoiosi, V. M., Siracusa, V. & Caccamo, F. (1995). Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens. Journal of Chemotherapy 7, 530-4.
11. Malmborg, A. S. & Ahlen, S. (1993). In-vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens. Chemotherapy 39, 32-5.
12. Lode, H., Garau, J., Grassi, C., Hosie, J., Huchon, G., Legakis, N. et al. (1995). Treatment of community acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. European Respiratory Journal 8, 1999-2007.
13. Portier, H., May, T., Proust, A. & The French Study Group. (1996). Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community acquired pneumonia. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 83-91.
14. Allegra, L, Konietzko, N., Leophonte, P., Hosie, J., Pauwels, R. et al. (1996). Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind randomised, parallel, multicentre study. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 93-104.
15. Baquero, F., Martinez-Beltran, J. & Loza, E. (1991). A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. Journal of Antimicrobial Chemotherapy 28, Suppl C, 31-8.
16. Geslin, P., Fremaux, A. & Sissia, G. (1993). Situation actuelle de la résistance des pneumocoques'aux antibiotiques en France: bilan du Centre National-de Référence. La Lettre de l'Infectiologue 8, 477-86.
17. Linares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F. et al. (1992). Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge hospital, Barcelona, Spain (1979-1990). Clinical Infectious Diseases 15, 99-105.
18. Marton, A. (1992). Pneumococcal antimicrobial resistance: the problem in Hungary. Clinical Infectious Diseases 15, 106-11.
19. Smith, S. M., Eng, R. H. K., Bais, P., Fan-Harvard, P. & Tescon-Tumang, F. (1990). Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 26, 567-72.
20. Loo, V. G., Lavallee, J., McAlear, D. & Robson. H. G. (1994). The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones. Journal of Antimicrobial Chemotherapy 33, 641-5.
21. Facklam, R. R. & Washington, J. A. (1991). Streptococcus and related catalase-negative Gram-positive cocci. In Manual of Clinical Microbiology (Balows, A., Hausler, W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 238-57. American Society for Microbiology, Washington, DC.
22. Kilian, M. (1991). Haemophilus. In Manual of Clinical Microbiology (Balows, A., Hausler, W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 463-70. American Society for Microbiology, Washington, DC.
23. Morello, J. A., Janda, W. M. & Doern, G. V. (1991). Neisseria and Branhamella. In Manual of Clinical Microbiology (Balows, A., Hausler, W. J., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds), pp. 258-76. American Society for Microbiology, Washington, DC.
24. Felmingham, D., Grüneberg, R. & The Alexander Project Collaborative Group. (1996). A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. Journal ofAntimicrobial Chemotherapy38, Suppl. A, 1-57.
25. Fung, C.-P., Yeo, S.-F. & Livermore, D. M. (1994). Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase. Journal of Antimicrobial Chemotherapy 33, 215-22.
26. Doern, G. V. & The Alexander Project Collaborative Group. (1996). Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-1993 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 59-69.
27. Doern, G. V. (1995). Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. American Journal of Medicine 99, 3S-7S.
28. Berk, S. L, Kalbfleisch, J. H. & The Alexander Project Collaborative Group. (1996). Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 85-96.
29. Gould, I. M., Forbes, K. J. & Gordon, G. S. (1994). Quinolone resistant Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 33, 187-8.
30. Bootsma, H. J., Troelstra, A., van Veen-Rutgers, A., Mooi, F. R., de Neeling, A. J. & Overbeek, B. P. (1997). Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from the Netherlands. Journal of Antimicrobial Chemotherapy 39, 85-96.
31. Piddock, L. J. V. & Jin, Y. F. (1992). Selection of quinolone resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 30, 109-10.